Cencora EBITDA 2010-2025 | COR

Cencora annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Cencora EBITDA for the quarter ending March 31, 2025 was $1.300B, a 56.08% increase year-over-year.
  • Cencora EBITDA for the twelve months ending March 31, 2025 was $3.648B, a 0.15% increase year-over-year.
  • Cencora 2024 annual EBITDA was $3.294B, a 0.83% decline from 2023.
  • Cencora 2023 annual EBITDA was $3.322B, a 7.98% increase from 2022.
  • Cencora 2022 annual EBITDA was $3.076B, a 6.05% increase from 2021.
Cencora Annual EBITDA
(Millions of US $)
2024 $3,294
2023 $3,322
2022 $3,076
2021 $2,901
2020 $-4,366
2019 $1,609
2018 $2,013
2017 $1,493
2016 $1,918
2015 $678
2014 $979
2013 $1,069
2012 $1,444
2011 $1,296
2010 $1,181
2009 $978
Cencora Quarterly EBITDA
(Millions of US $)
2025-03-31 $1,300
2024-12-31 $988
2024-09-30 $406
2024-06-30 $953
2024-03-31 $833
2023-12-31 $1,101
2023-09-30 $761
2023-06-30 $947
2023-03-31 $805
2022-12-31 $809
2022-09-30 $629
2022-06-30 $663
2022-03-31 $960
2021-12-31 $825
2021-09-30 $768
2021-06-30 $752
2021-03-31 $729
2020-12-31 $652
2020-09-30 $-5,652
2020-06-30 $504
2020-03-31 $410
2019-12-31 $373
2019-09-30 $293
2019-06-30 $519
2019-03-31 $184
2018-12-31 $613
2018-09-30 $341
2018-06-30 $535
2018-03-31 $607
2017-12-31 $531
2017-09-30 $-23
2017-06-30 $278
2017-03-31 $731
2016-12-31 $506
2016-09-30 $328
2016-06-30 $629
2016-03-31 $1,050
2015-12-31 $-89
2015-09-30 $620
2015-06-30 $403
2015-03-31 $-308
2014-12-31 $-37
2014-09-30 $266
2014-06-30 $160
2014-03-31 $347
2013-12-31 $205
2013-09-30 $158
2013-06-30 $178
2013-03-31 $392
2012-12-31 $341
2012-09-30 $361
2012-06-30 $361
2012-03-31 $409
2011-12-31 $313
2011-09-30 $245
2011-06-30 $349
2011-03-31 $396
2010-12-31 $307
2010-09-30 $250
2010-06-30 $308
2010-03-31 $336
2009-12-31 $288
2009-09-30 $250
2009-06-30 $237
2009-03-31 $271
Sector Industry Market Cap Revenue
Medical Medical Services $56.658B $293.959B
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.850B 26.98
Elevance Health (ELV) United States $84.468B 10.90
CVS Health (CVS) United States $83.959B 10.44
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.415B 0.00
Labcorp Holdings (LH) United States $21.653B 17.56
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.432B 0.00
Solventum (SOLV) United States $12.967B 13.73
CochLear (CHEOY) Australia $12.826B 0.00
ICON (ICLR) Ireland $11.783B 10.95
Revvity (RVTY) United States $11.516B 19.82
Viatris (VTRS) United States $10.434B 3.58
Avantor (AVTR) United States $9.254B 13.45
HealthEquity (HQY) United States $8.991B 39.38
Medpace Holdings (MEDP) United States $8.943B 23.75
Sonic Healthcare (SKHHY) Australia $8.181B 0.00
Charles River Laboratories (CRL) United States $7.378B 14.46
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.305B 25.35
BrightSpring Health Services (BTSG) United States $3.975B 36.47
Sotera Health (SHC) United States $3.162B 17.97
Surgery Partners (SGRY) United States $2.782B 36.18
Alignment Healthcare (ALHC) United States $2.710B 0.00
Concentras Parent (CON) United States $2.631B 15.21
Organon (OGN) United States $2.600B 2.76
GeneDx Holdings (WGS) United States $2.537B 97.72
PACS (PACS) United States $1.951B 0.00
Ardent Health (ARDT) United States $1.877B 8.00
Premier (PINC) United States $1.799B 13.66
Progyny (PGNY) United States $1.792B 39.45
GoodRx Holdings (GDRX) United States $1.754B 35.07
Teladoc Health (TDOC) United States $1.328B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
Establishment Labs Holdings (ESTA) $1.084B 0.00
CareDx (CDNA) United States $1.064B 16.62
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.670B 10.14
LifeMD (LFMD) United States $0.584B 0.00
Embecta (EMBC) United States $0.580B 3.91
InnovAge Holding (INNV) United States $0.516B 0.00
Enhabit (EHAB) United States $0.476B 39.17
Auna S.A (AUNA) Luxembourg $0.464B 10.45
Sonida Senior Living (SNDA) United States $0.455B 0.00
Omada Health (OMDA) $0.452B 0.00
SBC Medicals (SBC) United States $0.442B 0.00
Performant Healthcare (PHLT) United States $0.301B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.258B 0.00
Beauty Health (SKIN) United States $0.242B 0.00
Oncology Institute (TOI) United States $0.192B 0.00
So-Young (SY) China $0.189B 0.00
DocGo (DCGO) United States $0.165B 27.00
Pheton Holdings (PTHL) China $0.113B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.095B 0.00
KindlyMD (NAKA) United States $0.085B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
ModivCare (MODV) United States $0.049B 0.00
Biodesix (BDSX) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00